Physical Therapy Management of Wiedemann-Steiner Syndrome From Birth to 3 Years.
Abnormalities, Multiple
/ rehabilitation
Child, Preschool
Contracture
/ rehabilitation
Facies
Female
Growth Disorders
/ rehabilitation
Humans
Infant
Infant, Newborn
Intellectual Disability
/ rehabilitation
Male
Microcephaly
/ rehabilitation
Motor Skills Disorders
/ rehabilitation
Pediatrics
/ standards
Physical Therapy Modalities
/ standards
Practice Guidelines as Topic
Treatment Outcome
Journal
Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association
ISSN: 1538-005X
Titre abrégé: Pediatr Phys Ther
Pays: United States
ID NLM: 8912748
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
entrez:
1
7
2020
pubmed:
1
7
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
To investigate Wiedemann-Steiner syndrome (WSS), its correlation to hypotonia and developmental delay, and to determine the relative intervention strategies that may be useful during early intervention from birth to 3 years. A literature search using PEDro and PubMed was conducted using key words "Wiedemann-Steiner syndrome," "hypotonia," and "developmental delay" and a case study is presented. A 36-month-old child with WSS received PT intervention beginning at 2 months old. Addition of orthotics and treadmill walking was added at 13 and 19 months, respectively. The child progressed through developmental sequences from rolling, sitting, standing, and walking although consistently scored with motor delay of -2 SD. Fifty-seven percent of children diagnosed with WSS have hypotonia, and 90% have developmental delay. The diagnosis of WSS should require physical therapy services through early intervention programs due to its high correlation with motor developmental delay and disability. Determination of progress should be measured with achievement of function rather than norm-referenced outcome measures.Video Abstract: For more insights from the authors, access Supplemental Digital Content 1, available at: http://links.lww.com/PPT/A292.
Identifiants
pubmed: 32604375
doi: 10.1097/PEP.0000000000000714
pii: 00001577-202007000-00025
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E64-E69Références
Stellacci E, Onesimo R, Bruselles A, et al. Congenital Immunodeficiency in an individual with Wiedemann-Steiner syndrome due to a novel missence mutation in KMT2A. Am J Med Genet A. 2016;170(9):2389–2393. doi:10.1002/ajmd.a.37681.
Steiner CE, Marques AP. Growth deficiency, mental retardation and unusual facies. Clin Dysmorphol. 2000;9(2):155–156.
Wiedemann HR, Kunze J, Grosse FR, Dibbern HA. A syndrome of abnormal facies, short stature, and psychomotor retardation. In: Kahler SG, ed. Atlas of Clinical Syndromes: A Visual Aid to Diagnosis for Clinicians and Practicing Physicians. 2nd ed. London, England: Wolfe Publishing Ltd; 1989:198–199.
Aggarwal A, Rodriquez-Buritica DF, Northrup H. Wiedemann-Steiner syndrome: novel pathogenic variant and review of literature. Eur J Med Genet. 2017;60(6):285–288. doi:10.1016/j.ejmg.2017.03.006.
Mendelsohn BA, Pronold M, Long R, Smaoui N, Slavotinek AM. Advanced bone age in a girl with Wiedemann-Steiner syndrome and an exonic deletion in KMT2A (MLL). Am J Med Genet A. 2014;164A(8):2079–2083. doi:10.1002/ajmg.a.36590.
Steel D, Salpeitro V, Phadke R, et al. Whole exome sequencing reveals a MLL de novo mutation associated with mild developmental delay and without “hairy elbows”: expanding the phenotype of Wiedemann-Steiner syndrome. J Genet. 2015;94(4):755–758
Strom SP, Lozano R, Lee H, et al. De novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing. BMC Med Genet. 2014;15:49. doi:10.1186/1471-2350-15-49.
Sun Y, Hu G, Liu H, et al. Further delineation of the phenotype of truncating KMT2A mutations: the extended Wiedemann-Steiner syndrome. Am J Med Genet A. 2017;173(2):510–514.
Jones WD, Dafou D, McEntagart M, et al. De novo mutations in MLL cause Wiedemann-Steiner syndrome. Am J Hum Genet. 2012;91(2):358–364. doi:10.1016/j.ajhg.2012.06.008.
Jones WD. Genetic and Phenotypic Investigations Into Developmental Disorders [PhD dissertation]. Cambridge, England: University of Cambridge; 2017. ftp://ftp.sanger.ac.uk.pub/resources/theses/wj1/chapter2.pdf. Accessed August 10, 2018.
National Institutes of Health. Genetic and Rare Diseases (GARD) Information Center: Wiedemann-Steiner syndrome. https://rarediseases.info.nih.gov/diseases/5565/Wiedemann-steiner-syndrome Accessed August 5, 2018.
Dunkerton S, Field M, Cho V, et al. A de novo mutation in KMT2A (MLL) in monozygotic twins with Wiedemann-Steiner syndrome. Am J Med Genet A. 2015;167A:2182–2187. doi:10.1002/ajmg.a.37130.
Wiedemann-Steiner Foundation. WSS Conference 2017. https://www.wssfoundation.org/webinar2017. Accessed August 8, 2018.
Calvel P, Kusz-Zamelczyk K, Makrythanasis P, et al. A case of Wiedemann-Steiner syndrome associated with a 46,xy disorder of sexual development and gonadal dysgenesis. Sex Dev. 2015;9(5):289–295. doi:10.1159/000441512.
Ramirez-Montaño D, Pachajoa H. Wiedemann-Steiner syndrome with a novel pathogenic variant in KMT2A: a case report. Colomb Med (Cali). 2019;50(1):40–45. doi:10.25100/cm.v50il.3555.
Bogaert DJ, Dullaers M, Kuehn HS, et al. Early-onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedemann-Steiner and Roifman syndromes. Sci Rep. 2017;7(1):3702. doi:10:1038/s41598-017-02434-4.
Stoyle G, Banka S, Langley C, Jones EA, Banerjee I. Growth hormone deficiency as a cause for short stature in Wiedemann-Steiner syndrome. Endocrinol Diabetes Metab Case Rep. 2018;2018:18–0085. doi:10.1530/EDM-18-0085.
Chan AJS, Cytrynbaum C, Hoang N, et al. Expanding the neurodevelopmental phenotypes of individuals with de novo KMT2A variant. NPJ Genom Med. 2019;4:9. doi:10.1038/s41525-019-0083-x.
Baer S, Afenjar A, Smol T, et al. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases. Clin Genet. 2018;94(1):141–152. doi:10.1111/cge.13254.
World Health Organization. International Classification of Functioning and Health. Geneva, Switzerland: World Health Organization; 2001.
World Health Organization. How to Use the ICF: A Practical Manual For Using the International Classification of Functioning, Disability and Health. Exposure Draft for Comment. Geneva, Switzerland: World Health Organization; 2013.
Weber A, Martin K. The efficacy of orthoses for children with hypotonia: a systematic review. Pediatr Phys Ther. 2014;26(1):38–47. doi:10.1097/PEP.0000000000000011.
American Physical Therapy Association. Section on Pediatrics Fact Sheet: Body-Weight-Supported Treadmill Training: Using Evidence to Guide Physical Therapy Intervention. Alexandria, VA: American Physical Therapy Association; 2010.
Valentin-Gudiol M, Bagur-Calafat C, Girabent-Farres M, Hadders-Algra M, Mattern-Baxter K, Angulo-Barroso R. Treadmill interventions with partial body weight support in children under six years of age at risk of neuromotor delay: a report of a Cochrane systematic review and meta-analysis. Eur J Phys Rehabil Med. 2013;49(1):67–91.
New York State Department of Health. Clinical Practice Guideline: Quick Reference Guide for Motor Disorders, Assessment and Intervention for Young Children (Ages 0-3 years). Publication No. 4961. New York, NY: New York State Department of Health; 2006.
Li N, Wang Y, Yang Y, et al. Description of the molecular and phenotypic spectrum of Wiedemann-Steiner syndrome in Chinese patients. Orphanet J Rare Dis. 2018;13:178. doi:10.1186/s13023-018-0909-0.